Related Experiment Video
Updated: Jul 17, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?
Maryne Dupuy1, Maxime Gueguinou2, Marie Potier-Cartereau2
1Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44000 Nantes, France.
Abstract:
Ion channels are transmembrane structures that allow the passage of ions across cell membranes such as the plasma membrane or the membranes of various organelles like the nucleus, endoplasmic reticulum, Golgi apparatus or mitochondria. Aberrant expression of various ion channels has been demonstrated in several tumor cells, leading to the promotion of key functions in tumor development, such as cell proliferation, resistance to apoptosis, angiogenesis, invasion and metastasis. The link between ion channels and these key biological functions that promote tumor development has led to the classification of cancers as oncochannelopathies. Among all ion channels, the most varied and numerous, forming the largest family, are the potassium channels, with over 70 genes encoding them in humans. In this context, this review will provide a non-exhaustive overview of the role of plasma membrane potassium channels in cancer, describing 1) the nomenclature and structure of potassium channels, 2) the role of these channels in the control of biological functions that promotes tumor development such as proliferation, migration and cell death, and 3) the role of two particular classes of potassium channels, the SKCa- and Kv1- type potassium channels in cancer progression.
Insights
This review explores how potassium channels, crucial for cell function, are implicated in cancer development. Understanding these oncochannelopathies offers new insights into cancer progression and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Ion channels are vital transmembrane proteins regulating ion transport across cellular membranes.
- Dysregulated ion channel expression is linked to key cancer hallmarks like proliferation, apoptosis resistance, and metastasis.
- Cancers driven by ion channel dysfunction are termed oncochannelopathies.
Purpose of the Study:
- To provide an overview of plasma membrane potassium channels in cancer.
- To describe potassium channel nomenclature, structure, and their role in tumor-promoting functions.
- To highlight the involvement of SKCa- and Kv1- potassium channels in cancer progression.
Main Methods:
- Literature review focusing on potassium channels and cancer.
- Analysis of existing research on ion channel function in tumor biology.
- Specific examination of SKCa- and Kv1- channel roles in cancer progression.
Main Results:
- Potassium channels are a large, diverse family of ion channels with significant roles in cancer.
- Aberrant potassium channel activity promotes cancer cell proliferation, migration, and survival.
- SKCa- and Kv1- channels are specifically implicated in advancing cancer progression.
Conclusions:
- Plasma membrane potassium channels are critical regulators of cancer cell behavior.
- Targeting specific potassium channels presents a potential strategy for cancer therapy.
- Further research into oncochannelopathies, particularly potassium channels, is warranted.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

